| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4460377
Max Phase: Preclinical
Molecular Formula: C18H15N5OS2
Molecular Weight: 381.49
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CSc1ccc(NC(=O)c2cnc(Nc3ccc4[nH]ncc4c3)s2)cc1
Standard InChI: InChI=1S/C18H15N5OS2/c1-25-14-5-2-12(3-6-14)21-17(24)16-10-19-18(26-16)22-13-4-7-15-11(8-13)9-20-23-15/h2-10H,1H3,(H,19,22)(H,20,23)(H,21,24)
Standard InChI Key: NTQYVQVIPYUHQW-UHFFFAOYSA-N
Associated Targets(Human)
HDQ-P1 (69 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 381.49 | Molecular Weight (Monoisotopic): 381.0718 | AlogP: 4.74 | #Rotatable Bonds: 5 |
| Polar Surface Area: 82.70 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.79 | CX Basic pKa: 2.13 | CX LogP: 3.93 | CX LogD: 3.93 |
| Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.44 | Np Likeness Score: -2.31 |
References
| 1. Rabea SM, Baradaran-Heravi A, Balgi AD, Krause A, Hosseini Farahabadi S, Roberge M, Grierson DS.. (2019) 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides., 10 (5): [PMID:31097990] [10.1021/acsmedchemlett.8b00610] |
Source
Source(1):